core product, a robotic imaging platform, uses a robotic arm to scan a patient’s skin and generate standardized dermoscopic images within minutes, creating a detailed digital record of the entire body. These images are paired with AI-driven software that assists clinicians in identifying and tracking new or changing lesions over time, supporting early detection of conditions such as melanoma while leaving final diagnosis decisions to physicians.

The company integrates robotics, computer vision, and machine learning to automate data capture and improve consistency across dermatological exams. Its technology is designed to reduce manual workload, improve documentation accuracy, and enable longitudinal tracking of patient skin health through structured datasets. SquareMind’s platform is used by dermatologists and healthcare providers seeking to manage increasing patient volumes and enhance diagnostic workflows. The system supports clinical environments by combining automated imaging, data analysis, and digital recordkeeping into a unified workflow.

The company operates within the digital health and medical robotics sector, focusing on improving access to high-quality skin screening and enabling more efficient use of clinical resources through integrated AI-driven tools.